What is LOPJLB’s current signal on LTGO?

LOPJLB’s latest quantitative signal on Latigo Biotherapeutics Inc. (LTGO) is SELL. Signals are updated daily.

What market regime is LTGO in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Latigo Biotherapeutics Inc. (LTGO) do?

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquarte…